Sector Update: Health Care Stocks Edge Higher Premarket Tuesday

MT Newswires Live

Jun 24

Health care stocks were edging higher premarket Tuesday with the iShares Biotechnology ETF (IBB) advancing by 0.8% and the Health Care Select Sector SPDR Fund (XLV) recently up 0.6%.

Nektar Therapeutics (NKTR) shares were surging by more than 110% after the company said the phase 2b study of investigational rezpegaldesleukin met its primary endpoint in patients with moderate to severe atopic dermatitis.

Amarin (AMRN) shares were up nearly 9% after the company said it signed an exclusive license and supply agreement with Recordati to commercialize Vazkepa in 59 European countries.

Nuvation Bio (NUVB) shares were more than 2% higher after the compay said taletrectinib has been added as a preferred agent in the updated National Comprehensive Cancer Network clinical practice guidelines for non-small cell lung cancer, or NSCLC.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2545728061"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2545728061\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2545728061?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-24 21:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2545728061","market":"us","top_or_hot":-1,"title":"Sector Update: Health Care Stocks Edge Higher Premarket Tuesday","media":"MT Newswires Live","content":"<html><body><p> Health care stocks were edging higher premarket Tuesday with the <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) advancing by 0.8% and the Health Care Select Sector SPDR Fund (XLV) recently up 0.6%.</p><p>Nektar <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (NKTR) shares were surging by more than 110% after the company said the phase 2b study of investigational rezpegaldesleukin met its primary endpoint in patients with moderate to severe atopic dermatitis.</p><p>Amarin (AMRN) shares were up nearly 9% after the company said it signed an exclusive license and supply agreement with Recordati to commercialize Vazkepa in 59 European countries.</p><p><a href=\"https://laohu8.com/S/NUVB\">Nuvation Bio</a> (NUVB) shares were more than 2% higher after the compay said taletrectinib has been added as a preferred agent in the updated National Comprehensive Cancer Network clinical practice guidelines for non-small cell lung cancer, or NSCLC.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sector Update: Health Care Stocks Edge Higher Premarket Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSector Update: Health Care Stocks Edge Higher Premarket Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-06-24 21:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Health care stocks were edging higher premarket Tuesday with the <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) advancing by 0.8% and the Health Care Select Sector SPDR Fund (XLV) recently up 0.6%.</p><p>Nektar <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (NKTR) shares were surging by more than 110% after the company said the phase 2b study of investigational rezpegaldesleukin met its primary endpoint in patients with moderate to severe atopic dermatitis.</p><p>Amarin (AMRN) shares were up nearly 9% after the company said it signed an exclusive license and supply agreement with Recordati to commercialize Vazkepa in 59 European countries.</p><p><a href=\"https://laohu8.com/S/NUVB\">Nuvation Bio</a> (NUVB) shares were more than 2% higher after the compay said taletrectinib has been added as a preferred agent in the updated National Comprehensive Cancer Network clinical practice guidelines for non-small cell lung cancer, or NSCLC.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2545728061","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2545728061","pubTimestamp":1750770854,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Health care stocks were edging higher premarket Tuesday with the iShares Biotechnology ETF  advancing by 0.8% and the Health Care Select Sector SPDR Fund  recently up 0.6%.Nektar Therapeutics  shares were surging by more than 110% after the company said the phase 2b study of investigational rezpegaldesleukin met its primary endpoint in patients with moderate to severe atopic dermatitis.Amarin  shares were up nearly 9% after the company said it signed an exclusive license and supply agreement with Recordati to commercialize Vazkepa in 59 European countries.Nuvation Bio  shares were more than 2% higher after the compay said taletrectinib has been added as a preferred agent in the updated National Comprehensive Cancer Network clinical practice guidelines for non-small cell lung cancer, or NSCLC.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","NKTR":"内克塔治疗","AMRN":"阿玛琳","XLV":"健康照护类股ETF-SPDR","NUVB":"Nuvation Bio, Inc.","BK4588":"碎股","BK4585":"ETF&股票定投概念","IBB":"生物科技指数ETF-iShares Nasdaq","BK4139":"生物科技","BK4581":"高盛持仓"},"translate_title":"行业更新：医疗保健股周二盘前小幅走高","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMRN":0.9,"IBB":0.9,"NKTR":0.9,"NUVB":0.9,"XLV":0.9},"content_text":"Health care stocks were edging higher premarket Tuesday with the iShares Biotechnology ETF (IBB) advancing by 0.8% and the Health Care Select Sector SPDR Fund (XLV) recently up 0.6%.Nektar Therapeutics (NKTR) shares were surging by more than 110% after the company said the phase 2b study of investigational rezpegaldesleukin met its primary endpoint in patients with moderate to severe atopic dermatitis.Amarin (AMRN) shares were up nearly 9% after the company said it signed an exclusive license and supply agreement with Recordati to commercialize Vazkepa in 59 European countries.Nuvation Bio (NUVB) shares were more than 2% higher after the compay said taletrectinib has been added as a preferred agent in the updated National Comprehensive Cancer Network clinical practice guidelines for non-small cell lung cancer, or NSCLC.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}